CPC A61K 31/53 (2013.01) [A61K 9/0075 (2013.01); A61K 31/166 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 47/26 (2013.01); A61M 15/0008 (2014.02); A61M 2202/064 (2013.01)] | 37 Claims |
1. A pharmaceutical composition, comprising at least about 2% to about 20% by weight of a micronized hydrochloride salt of vardenafil based on the total weight of the pharmaceutical composition, wherein the micronized hydrochloride salt of vardenafil has a Dv50 of about 5 microns or less, and lactose having an average particle size between about 2 microns to about 250 microns and comprising a fine lactose fraction from about 2% to about 50% by weight of the total lactose component, wherein the fine lactose fraction has a particle size of less than 7 microns, and wherein the pharmaceutical composition is in dry powder form suitable for oral inhalation.
|